Butyrate stimulates cyclin D and p21 and inhibits cyclin-dependent kinase 2 expression in HT-29 colonic epithelial cells - PubMed (original) (raw)
. 1997 Mar 6;232(1):169-72.
doi: 10.1006/bbrc.1997.6255.
Affiliations
- PMID: 9125124
- DOI: 10.1006/bbrc.1997.6255
Butyrate stimulates cyclin D and p21 and inhibits cyclin-dependent kinase 2 expression in HT-29 colonic epithelial cells
S Siavoshian et al. Biochem Biophys Res Commun. 1997.
Abstract
Sodium butyrate, a product of colonic fermentation of dietary fiber, has been shown to inhibit cell proliferation by blocking the cells in the G1 phase of the cell cycle. However, its mechanism of action is still unknown. We found that butyrate strongly stimulated cyclin D and p21/WAF1/CIP1 expression in HT-29 human colonic adenocarcinoma cells, in a dose dependent manner. These stimulations were associated with a decrease in cyclin-dependent kinase (cdk) 2 level, whereas cdk4 and cdk6 remained unchanged. Our results suggest that the inhibition of cell cycle progression by sodium butyrate may be explained by a modulation of cell cycle regulatory proteins such as cyclin D and p21.
Similar articles
- TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
Kamesaki H, Nishizawa K, Michaud GY, Cossman J, Kiyono T. Kamesaki H, et al. J Immunol. 1998 Jan 15;160(2):770-7. J Immunol. 1998. PMID: 9551912 - Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells.
Damiens E, El Yazidi I, Mazurier J, Duthille I, Spik G, Boilly-Marer Y. Damiens E, et al. J Cell Biochem. 1999 Sep 1;74(3):486-98. J Cell Biochem. 1999. PMID: 10412049 - Probing protein-protein interactions with mass spectrometry.
Kriwacki RW, Siuzdak G. Kriwacki RW, et al. Methods Mol Biol. 2000;146:223-38. doi: 10.1385/1-59259-045-4:223. Methods Mol Biol. 2000. PMID: 10948505 Review. No abstract available. - Butyrolactone: more than a kinase inhibitor?
Bloom J, Pagano M. Bloom J, et al. Cell Cycle. 2002 Mar-Apr;1(2):117-8. doi: 10.4161/cc.1.2.114. Cell Cycle. 2002. PMID: 12429918 Review. No abstract available.
Cited by
- A Narrative Review: Immunometabolic Interactions of Host-Gut Microbiota and Botanical Active Ingredients in Gastrointestinal Cancers.
Li S, Feng W, Wu J, Cui H, Wang Y, Liang T, An J, Chen W, Guo Z, Lei H. Li S, et al. Int J Mol Sci. 2024 Aug 22;25(16):9096. doi: 10.3390/ijms25169096. Int J Mol Sci. 2024. PMID: 39201782 Free PMC article. Review. - Antioxidant Role of Probiotics in Inflammation-Induced Colorectal Cancer.
Hamamah S, Lobiuc A, Covasa M. Hamamah S, et al. Int J Mol Sci. 2024 Aug 20;25(16):9026. doi: 10.3390/ijms25169026. Int J Mol Sci. 2024. PMID: 39201713 Free PMC article. Review. - Sodium Butyrate (NaB) and Sodium Propionate (NaP) Reduce Cyclin A2 Expression, Inducing Cell Cycle Arrest and Proliferation Inhibition of Different Breast Cancer Subtypes, Leading to Apoptosis.
Ibrahim JN, El-Hakim S, Semaan J, Ghosn S, El Ayoubi H, Elnar AA, Tohme N, El Boustany C. Ibrahim JN, et al. Biomedicines. 2024 Aug 6;12(8):1779. doi: 10.3390/biomedicines12081779. Biomedicines. 2024. PMID: 39200243 Free PMC article. - Epigenetic effects of short-chain fatty acids from the large intestine on host cells.
Stein RA, Riber L. Stein RA, et al. Microlife. 2023 Jun 16;4:uqad032. doi: 10.1093/femsml/uqad032. eCollection 2023. Microlife. 2023. PMID: 37441522 Free PMC article. Review. - The Modulatory Effects of Fatty Acids on Cancer Progression.
Westheim AJF, Stoffels LM, Dubois LJ, van Bergenhenegouwen J, van Helvoort A, Langen RCJ, Shiri-Sverdlov R, Theys J. Westheim AJF, et al. Biomedicines. 2023 Jan 19;11(2):280. doi: 10.3390/biomedicines11020280. Biomedicines. 2023. PMID: 36830818 Free PMC article. Review.